Search

Search Constraints

You searched for: Author/Creator Fenton, David

Search Results

2. Association of age with differences in immune related adverse events and survival of patients with advanced nonsmall cell lung cancer receiving pembrolizumab or nivolumab. Issue 5 (June 2020)

7. Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice. (July 2019)